Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy-Breakthrough in Low-Density Lipoprotein Cholesterol Lowering, Breakdown in Value.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Mark, DB; Richman, I; Hlatky, MA

Published Date

  • October 1, 2017

Published In

Volume / Issue

  • 2 / 10

Start / End Page

  • 1066 - 1068

PubMed ID

  • 28832860

Pubmed Central ID

  • 28832860

Electronic International Standard Serial Number (EISSN)

  • 2380-6591

Digital Object Identifier (DOI)

  • 10.1001/jamacardio.2017.2911

Language

  • eng

Conference Location

  • United States